Radouane zouaoui

Radouane Zouaoui has a diverse work experience in the field of scientific research and development. Radouane is currently serving as a Principal Scientist at Landmark Bio since June 2022. Prior to this, they worked as a Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson from October 2020 to May 2022.

Before joining these companies, Radouane worked at Momenta Pharmaceuticals for a significant period of time. Radouane'sroles at Momenta Pharmaceuticals include Scientist, Associate Scientist, and Senior Research Associate. As a Scientist, they were part of the Biological discovery group and contributed to the purification, formulation, and characterization of monoclonal antibodies for animal studies. Radouane developed purification techniques, managed a team, and optimized chromatography techniques to scale them up.

In their role as an Associate Scientist and Senior Research Associate, Radouane worked with the API group for process development and tech transfer. Radouane played a key role in developing a robust and reproducible M402 process and facilitating its transfer to a contract manufacturing organization (CMO). Additionally, they supported the chemistry group by synthesizing oligosaccharides for structure-activity relationship (SAR) studies and generating a library of LMWH for oncology and drug delivery research.

Overall, Radouane Zouaoui has a strong background in scientific research, process development, and project management in the pharmaceutical industry.

From 2001 to 2004, Radouane Zouaoui pursued a Master's degree in Chemistry at UMass Boston.